Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 June 2020 | Story Amanda Thongha

WATCH: Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, Prof Hendri Kroukamp, the Dean of the Faculty of Economic and Management Sciences, Susan Van Jaarveld, Senior Director at the Department of Human Sources, and Brandon Jacobs, Head of Retail and Business Banking at Standard Bank, Central Free State explain what the “I Am’ Wellness programme is about.

 

Maintaining a healthy work-life balance continues to be a juggling act for most, more so during this uncertain time dominated by COVID-19. To help individuals cope with life challenges, the University of the Free State (UFS) has launched a new short learning programme that addresses all aspects of well-being.

The ‘I Am’ Wellness short learning programme, open to UFS staff, private individuals, and businesses, kicks off on 19 June 2020. A number of prominent South Africans participating in the launch of the ‘I Am’ Wellness short learning programme are, among others, Kovsie alumna and former Miss World, Rolene Strauss; former Miss South Africa, Amy Kleinhans; and motivational speaker and author, Alison Botha. Former Public Protector Thuli Madonsela rounds off the list of public figures who have also expressed interest in the programme.

Burneline Kaars, Head of Organisational Development and Employee Wellness at the UFS, says those interested in the programme can look forward to content focusing on different topics and themes related to wellness aspects. Participants will discover the fun of finding ways to improve their health and well-being through activities, games, quizzes, and many more.

“Upon completion of this programme, participants will be equipped to understand and improve their own personal and work-related well-being. They will be empowered to increase their own well-being and reach their optimal potential in both their personal and work life.”

The programme, a joint effort of the UFS Division of Organisational Development and Employee Wellness and the UFS Department of Industrial Psychology, can be completed online or as part of contact sessions, depending on the needs of the participants. Participants need to avail themselves four hours a week to successfully complete the programme. Those who master the two-month programme will also receive a certificate of completion from the UFS.

The programme is offered to UFS staff at no cost. External audiences will pay R9 500 per person to complete the programme. Groups of 10 and more will get a special discount when signing up.

Registration for the formal programme opens on Wednesday, 24 June 2020.

For more information, contact Burneline Kaars at KaarsB@ufs.ac.za.


Other programmes done by the UFS Organisational Development and Employee Wellness office:


First #MentalHealth awareness run to Stellenbosch to bring hope
Kovsies pedal smoothie bike for #MentalHealth

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept